Fannin Innovation Studio is an early-stage life science development group focused on commercializing innovation developed in the Texas Medical Center institutions. Fannin provides its startups with central office space, seed capital, and a vast network of resources. To address the root cause of Houston’s commercialization gap, the company works directly with the city’s top-tier, higher education institutions to recruit aspiring entrepreneurs to join its apprenticeship program which provides on-the-job training to collaboratively lead its portfolio companies from innovation to commercialization.
Allterum Therapeutics is a biopharmaceutical company that develops treatments for relapsed acute lymphoblastic leukemia and other IL-7R expressing cancers. The company is also exploring relapsed/refractory solid tumors with IL-7R over-expression. The 4A10 antibody was developed at the National Cancer Institutes (NCI) and licensed exclusively to Fannin Innovation Studio.